Although fully organized patient-run trials are still few and far between, patients are taking a more active role in clinical research.
Advertisement
The Scientist
Most Recent
Contributors
| March 1, 2013
Meet some of the people featured in the March 2013 issue of The Scientist.
Patients are sidestepping clinical research and using themselves as guinea pigs to test new treatments for fatal diseases. Will they hurt themselves, or science?
During development, communication between organs determines their relative final size.
Three Silicon Valley entrepreneurs are offering $3 million to scientists demonstrating excellence in biology and medical research.
The first human trial of a treatment using induced pluripotent stem cells has received conditional approval from an institutional review board in Japan.
Under new plans to reduce the European Union’s overall spending, science funding did relatively well, but research leaders want more—and they may well get it.
Engineer and materials scientist Subra Suresh will become president of Carnegie Mellon University.
Tuberculosis bacteria find shelter from drugs and the body’s defenses in bone marrow stem cells.
Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
